71 research outputs found

    Impact of CRAB symptoms in survival of patients with symptomatic myeloma in novel agent era

    Get PDF
    The acronym CRAB summarizes the most typical clinical manifestations of multiple myeloma, these being hypercalcemia, renal failure, anemia, and bone disease. CRAB can be used to distinguish between active, symptomatic multiple myeloma and monoclonal gammopathy of undermined significance or smoldering myeloma. The distinction is relevant not only for classification and diagnosis but also for therapy. CRAB factors influence the prognosis of multiple myeloma. However, it is unclear whether the presence of CRAB factors has an influence on the prognosis of myeloma treated with novel agents. In the current study, patients with hypercalcemia and bone disease showed a significantly worse prognosis, whereas anemia and renal failure showed no difference in survival. Novel agents used for treatment of patients with renal failure suggested a favorable outcome compared with conventional therapy. Bone disease was the most common factor and may have the strongest prognostic value in symptomatic myeloma patients using novel agents

    Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia

    Get PDF
    Dasatinib is currently approved for clinical use as a first-line treatment agent for newly diagnosed chronic myeloid leukemia (CML). However, only a few clinical trials have been performed to evaluate dasatinibinduced PE following first-line therapy. We investigated the incidence and clinical features of dasatinib-induced PE following first-line therapy in Japanese CML patients of real world clinical practice settings. Among 22 patients, the median age of PEpositive patients was higher than that of PEnegative patients. Major molecular response was achieved in 75% of PE-positive patients and 50% of PE-negative patients. Most patients developed PE more than 1 year after treatment. Appearance of PE is associated with better clinical response during dasatinib treatment, however it is developed at any time. Elderly and high-risk patients tend to develop PE. The clinical features of dasatinib-induced PE following first-line therapy might be late onset and might not immediately follow the increasing of large granular lymphocyte

    JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression

    Get PDF
    Tumor stem cells (TSCs), capable of self-renewal and continuous production of progeny cells, could be potential therapeutic targets. We have recently reported that chromatin remodeling regulator Brg1 is required for maintenance of murine intestinal TSCs and stemness feature of human colorectal cancer (CRC) cells by inhibiting apoptosis. However, it is still unclear how BRG1 suppression changes the underlying intracellular mechanisms of human CRC cells. We found that Brg1 suppression resulted in upregulation of the JNK signaling pathway in human CRC cells and murine intestinal TSCs. Simultaneous suppression of BRG1 and the JNK pathway, either by pharmacological inhibition or silencing of c-JUN, resulted in even stronger inhibition of the expansion of human CRC cells compared to Brg1 suppression alone. Consistently, high c-JUN expression correlated with worse prognosis for survival in human CRC patients with low BRG1 expression. Therefore, the JNK pathway plays a critical role for expansion and stemness of human CRC cells in the context of BRG1 suppression, and thus a combined blockade of BRG1 and the JNK pathway could be a novel therapeutic approach against human CRC

    Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis

    Get PDF
    膵癌悪性化の分子機構解明 --RECK発現の低下が膵癌の浸潤・転移を引き起こす--. 京都大学プレスリリース. 2023-09-19.RECK is downregulated in various human cancers; however, how RECK inactivation affects carcinogenesis remains unclear. We addressed this issue in a pancreatic ductal adenocarcinoma (PDAC) mouse model and found that pancreatic Reck deletion dramatically augmented the spontaneous development of PDAC with a mesenchymal phenotype, which was accompanied by increased liver metastases and decreased survival. Lineage tracing revealed that pancreatic Reck deletion induced epithelial-mesenchymal transition (EMT) in PDAC cells, giving rise to inflammatory cancer-associated fibroblast–like cells in mice. Splenic transplantation of Reck-null PDAC cells resulted in numerous liver metastases with a mesenchymal phenotype, whereas reexpression of RECK markedly reduced metastases and changed the PDAC tumor phenotype into an epithelial one. Consistently, low RECK expression correlated with low E-cadherin expression, poor differentiation, metastasis, and poor prognosis in human PDAC. RECK reexpression in the PDAC cells was found to downregulate MMP2 and MMP3, with a concomitant increase in E-cadherin and decrease in EMT-promoting transcription factors. An MMP inhibitor recapitulated the effects of RECK on the expression of E-cadherin and EMT-promoting transcription factors and invasive activity. These results establish the authenticity of RECK as a pancreatic tumor suppressor, provide insights into its underlying mechanisms, and support the idea that RECK could be an important therapeutic effector against human PDAC

    Long distance fast data transfer experiments for the ITER Remote Experiment

    Get PDF
    Developing effective and fast data transfer system for the huge amount data between Europe and Japan is a critical issue for the ITER Remote Experimentation Center (REC). To implement the system, effective data transfer methods and wide bandwidth international network are required.This paper describes results of data transfer experiments. We have evaluated two data transfer methods: Packet Pacing and MMCFTP. By using Packet Pacing and 2.4 Gbps line, we achieved 2.2 Gbps data transfer from NIFS to IFERC. By using MMCFTP and 10 Gbps line, we achieved 2.5 Gbps data transfer from NIFS to Dublin, Ireland. Furthermore, by using MMCFTP and 100Gbps line, we successfully achieved the stable transmission of 1PB of data at approximately 84 Gbps, one of the world’s fastest transmission speeds.This paper also describes the upgrade plan of SINET (a Japanese academic backbone network), which is used for ITER and REC communications. SINET will be upgraded to the network based on 100-Gigabit Ethernet technology in April 2016. Furthermore, direct lines of 20 Gbps (10 Gbps × 2) between Japan and Europe will be introduced. These direct lines will reduce latency between Europe and Japan and will realize higher speed data transfer.•This paper presents fast data transfer experiments using packet pacing and mmcftp and results.•An upgrade plan of Japanese Academic Network SINET is also described.•To send the huge amount of data from ITER to the ITER Remote Experiment Center (REC), effective transfer method and super high-speed internationalnetwork are required.•This paper presents a progress of the investigation for fast transfer method

    High-performance data transfer for full data replication between iter and the remote experimentation centre

    Get PDF
    A high-performance data transfer method has been developed for the Remote Experimentation Centre (REC) of ITER in Japan for the first time. The developed technology shows the technical feasibility to establish the REC with full data replication between ITER and REC for remote experiments. Test results showed that it achieved a data transfer rate of approximately 7.9 Giga-bits per second (Gbps) on a 10-Gbps network. The new double-layer storage structure can accelerate the storage read/write speed up to 2 GByte/s. Moreover, the Internet and a layer-2 virtual private network (L2VPN) comparison tests demonstrated that the latter is superior in both security and speed. This technology shows great potential for near real-time full data replication between ITER and REC, which may provide a new style of world-wide remote experimentation

    Pikachurin Protein Required for Increase of Cone Electroretinogram B-Wave during Light Adaptation.

    No full text
    In normal eyes, the amplitude of the b-wave of the photopic ERGs increases during light adaptation, but the mechanism causing this increase has not been fully determined. The purpose of this study was to evaluate the contribution of receptoral and post-receptoral components of the retina to this phenomenon. To accomplish this, we examined the ERGs during light adaptation in Pikachurin null-mutant (Pika -/-) mice, which have a misalignment of the bipolar cell dendritic tips to the photoreceptor ribbon synapses. After dark-adaptation, photopic ERGs were recorded from Pika -/- and wild type (WT) mice during the first 9 minutes of light adaptation. In some of the mice, post-receptoral components were blocked pharmacologically. The photopic b-waves of WT mice increased by 50% during the 9 min of light adaptation as previously reported. On the other hand, the b-waves of the Pika -/- mice decreased by 20% during the same time period. After blocking post-receptoral components, the b-waves were abolished from the WT mice, and the ERGs resembled those of the Pika -/- mice. The extracted post-receptoral component increased during light adaptation in the WT mice, but decreased for the first 3 minutes to a plateau in Pika -/- mice. We conclude that the normal synaptic connection between photoreceptor and retinal ON bipolar cells, which is controlled by pikachurin, is required for the ERGs to increase during light-adaptation. The contributions of post-receptoral components are essential for the photopic b-wave increase during the light adaptation
    corecore